Autopsy report · NCT03195660

Adherence to ASV Therapy in Heart Failure With Preserved Ejection Fraction Feasibility Study

“Funding for study was withdrawn”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 months before it stopped.
• 6 participants enrolled.
• Results were posted on the registry 3 years 6 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

ResMed

Sponsor type

Industry

Conditions

Heart Failure With Normal Ejection Fraction; Sleep Apnea

Interventions

ASV Therapy

Participants

6

Sites

4

Countries

Germany, United States

Trials that died the same way

• Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma
  “Study funding was withdrawn.” (97% match in meaning)
• The Influence of Probiotics on Body Weight and Composition
  “study withdrawn due to funding” (95% match in meaning)
• Pasireotide in Hyperinsulinemic Hypoglycemia
  “Funding was withdrawn by Sponsor prior to start of study” (90% match in meaning)
• Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study
  “Due to limited funding, the study is now being withdrawn.” (87% match in meaning)
• Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
  “The study withdrawn due to lack financial support” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.